Evidence map›Paper›PMID 34554501›Full record

ReviewBiologia futura2021

Biologia Futura: stories about the functions of β

Zsuzsa Bajtay

Open access · hybridAbstract readReview
PubMed Publisher
In one paragraph

Review in Biologia futura, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Structural biology of complement receptors.Frontiers in immunology · 2023
    Review
  2. Fibrin-Targeting Immunotherapy for Dementia.The journal of prevention of Alzheimer's disease · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Zsuzsa BajtayInstitute of Biology, Department of Immunology and MTA-ELTE Immunology Research Group, Eötvös Loránd University, Pázmány P. s. 1/C, Budapest, H-1117, Hungary. bajtay.zsuzsanna@ttk.elte.hu.ORCID http://orcid.org/0000-0002-0705-0321
Eötvös Loránd University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrins are essential membrane proteins that provide a tightly regulated link between the extracellular matrix and the intracellular cytoskeletal network. These cell surface proteins are composed of a non-covalently bound α chain and β chain. The leukocyte-specific complement receptor 3 (CR3, α

Indexed as

CD11b AntigenCD11c AntigenCD18 AntigensComplement C3bHumansIntegrin alphaXbeta2Macrophage-1 AntigenMacrophagesPhagocytesPhagocytosisCD11b AntigenCD11c AntigenCD18 AntigensComplement C3bIntegrin alphaXbeta2Macrophage-1 AntigenAdherenceComplement receptorHuman phagocytesPhagocytosisβ2-integrins

Identifiers

PMID34554501
OpenAlexW3127187980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.